Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TriReme Medical

TriReme Medical?uq=UG6efJS6
2005 FOUNDED
M&A STATUS
101-200 EMPLOYEES
Merger of Eq. LATEST DEAL TYPE
Description

Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex vascular disease. The company develops next generation percutaneous devices for the treatment of coronary and peripheral vascular disease. Its novel balloon and stent therapies are specifically designed for the large, unmet clinical needs in the complex coronary and peripheral artery disease markets, providing physicians with new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Primary Office
  • 7060 Koll Center Parkway
  • Suite 300
  • Pleasanton, CA 94566
  • United States

+1 (925) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TriReme Medical’s full profile, request a free trial.

TriReme Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger of Equals 11-Jul-2013 000.00 Completed Generating Revenue
6. Later Stage VC 28-Nov-2012 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 12-Oct-2010 0000 000.00 000.00 Completed Startup
4. Early Stage VC 10-Nov-2009 00.000 000.00 Completed Startup
3. Early Stage VC 16-Oct-2007 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 27-Apr-2006 $3.44M $5.36M 000.00 Completed Startup
1. Early Stage VC (Series A) 11-Nov-2005 $1.92M $1.92M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

TriReme Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 2,264,157 $0.001000 $0.12 $1.52 $1.52 1x $1.52 3.2%
Series A 2,271,276 $0.001000 $0.08 $1 $1 1x $1 3.21%
To view this company’s complete Cap Table, request access »

TriReme Medical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Adams Street Partners PE/Buyout Minority 000 0000 000000 0
Bio*One Capital Corporate Venture Capital Minority 000 0000 000000 0
Luminor Capital Venture Capital Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0
Yellowstone Capital Partners PE/Buyout Minority 000 0000 000000 0

TriReme Medical Executive Team (9)

Name Title Board
Seat
Contact
Info
Randal Farwell Chief Financial Officer
Maria Pizarro Executive Vice President and Vice President, Research & Development
John Molyneux Vice President, Manufacturing
Christopher Haig Vice President of Marketing, Sales and Business Development
Shiva Ardakani Vice President of Regulatory Affairs and Quality Assurance

3 Former Executives

You’re viewing 5 of 9 executives. Get the full list »